POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No6/2020
Date of issue:2020-03-05
Short name of the issuer
SOPHARMA AD
Subject
Sales revenues for February 2020
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Sopharma AD (the “Company”) notifies that for February 2020 the Company recorded a decrease in sales of 22% compared to the same month of 2019, incl. 1% decrease in sales for the domestic market and 30% decrease in export sales. In the first two months of 2020 the revenues from sales of production decreased by 15% compared to the same period of 2019, incl. 2% decrease in domestic sales and 20% increase in export sales.
Annexes
FileDescription
Sales_Revenues_for_February_2020 espi.pdfSales revenues for February 2020
SOPHARMA AD
(fullname of the issuer)
SOPHARMA ADFarmaceutyczny (far)
(short name of the issuer)(sector according to clasification of the WSE in Warsow)
1220Sofia
(post code)(city)
IlienskoShosse16
(street)(number)
+359 2 813 42 00+359 2 936 02 86
(phone number)(fax)
(e-mail)(web site)
nd
(NIP)(REGON)
SIGNATURE OF PERSONS REPRESENTING THE COMPANY
DateNamePosition / FunctionSignature
2020-03-05Ognian DonevExecutive Director
Sales_Revenues_for_February_2020 espi.pdf